Green Thumb Industries (GTBIF) Total Current Liabilities (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Total Current Liabilities came in at $194.2 million in Q1 2026, up 3.76% YoY from $187.1 million in Q1 2025, and up 9.5% on a QoQ basis from $177.3 million in Q4 2025.
Green Thumb Industries (GTBIF) Total Current Liabilities (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Total Current Liabilities data on file, last reported at $194.2 million in Q1 2026.
- Quarterly Total Current Liabilities rose 3.76% year-over-year to $194.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $194.2 million (up 3.76% YoY) and the FY2025 annual result came in at $177.3 million, up 7.48% from the prior year.
- Total Current Liabilities climbed to $194.2 million in Q1 2026, from $177.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $370.6 million in Q2 2024 to a low of $126.0 million in Q4 2023.
- A 5-year average of $180.9 million and a median of $175.3 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities jumped 111.44% — and 2025, when it tumbled 51.61%.
- Tracing GTBIF's Total Current Liabilities over 5 years: stood at $146.6 million in 2022, then fell by 14.0% to $126.0 million in 2023, then soared by 30.88% to $165.0 million in 2024, then grew by 7.48% to $177.3 million in 2025, then gained by 9.5% to $194.2 million in 2026.
- The last three Total Current Liabilities figures came in at $194.2 million (Q1 2026), $177.3 million (Q4 2025), and $241.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 218.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 218.80 Mn |
| Mar 31, 2026 | 194.16 Mn |
| Dec 31, 2025 | 177.32 Mn |
| Sep 30, 2025 | 241.55 Mn |
| Jun 30, 2025 | 179.33 Mn |
| Mar 31, 2025 | 187.12 Mn |
| Dec 31, 2024 | 164.97 Mn |
| Sep 30, 2024 | 160.67 Mn |
| Jun 30, 2024 | 370.58 Mn |
| Mar 31, 2024 | 175.05 Mn |
| Dec 31, 2023 | 126.05 Mn |
| Sep 30, 2023 | 149.88 Mn |
| Jun 30, 2023 | 175.26 Mn |
| Mar 31, 2023 | 186.94 Mn |
| Dec 31, 2022 | 146.57 Mn |
| Sep 30, 2022 | 129.44 Mn |
| Jun 30, 2022 | 131.97 Mn |
| Mar 31, 2022 | 179.18 Mn |
| Dec 31, 2021 | 204.38 Mn |
| Sep 30, 2021 | 165.30 Mn |